SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

GKB Ophthalmics informs about newspaper publication

19 Feb 2025 Evaluate
GKB Ophthalmics has attached copies of newspaper cuttings of the extract of Statement of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2024, published in The Financial Express (Mumbai Edition) and on Pudhari (Marathi) dated February 15, 2025. 

The above information is a part of company’s filings submitted to BSE.

GKB Ophthalmics Share Price

72.28 -2.57 (-3.43%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 549.10
Poly Medicure 1452.35
Laxmi Denta 190.85
Nureca Ltd. 257.75
Hemant Surgical Inds 296.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×